Cardiac Rhythm Management Devices Market, by Product Type (Cardiac Resynchronization Therapy Devices, Defibrillator, and Pacemakers), by End User (Hospitals, Home Care Settings, and Ambulatory Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : Dec 2018 |
  • Pages : 155 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Cardiac Rhythm Management Devices Market – Insights

Cardiac Rhythm Management (CRM) devices include pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. These devices perform various functions, including bradycardia pacing, cardiac resynchronization for heart failure, monitoring for arrhythmias, defibrillation, and anti-tachycardia pacing for tachyarrhythmia. Products such as cardiac resynchronization therapy can improve congestive heart failure symptoms by improving the timing of the heart’s contractions, resulting in pumping more blood to the body.

The global cardiac rhythm management devices market size was valued at US$ 19.05 billion in 2017, and is expected to witness a CAGR of 7.5% over the forecast period (2018 – 2026).

Global Cardiac Rhythm Management Devices Market Revenue (US$ Bn) Analysis, By Product Type, 2017

Cardiac Rhythm Management Devices  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Rising incidences of cardiac disorders worldwide is expected to drive the cardiac rhythm management devices market revenue

Rise in incidence of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is expected to fuel growth of the cardiac rhythm management devices market. According to WHO report, in 2015, cardiovascular diseases was the leading cause of deaths accounting for 17.7 million deaths, worldwide.

Furthermore, technological advancements in cardiac rhythm management devices is the major growth rendering factor for the industry. For instance, adoption of advanced technologies in cardiac pacemakers such as pacemakers with improved battery life and MRI safe-pacemakers, delay the progression of persistent atrial fibrillation (AF) in patients suffering from bradycardia. These advancements are gaining significant traction and are expected to fuel the demand for cardiac rhythm management devices. For instance, in February 2017, Abbott received the Food and Drug Administration (FDA) approval for its MR-conditional labeling for Assurity MRI pacemaker and the Tendril MRI pacing lead.

Moreover, introduction of remote technology in cardiac rhythm management devices is anticipated to drive market growth. Remote technology includes remote follow-up, in which data can be periodically downloaded from the device, either through patient interaction with a transmitter system or automatically with no patient participation. The technology allows clinicians to perform periodic routine patient check-ups remotely.

Cardiac Rhythm Management Devices Market Restraints

Despite tremendous rise in cardiac rhythm disorders worldwide, implantable pacemakers associated infections in cardiac patients can deter patients from using the products, negatively impacting growth of the cardiac rhythm management devices market. Many manufacturers in the industry are claiming risks associated with their products. For instance, according to the Medtronic, risks associated with an ICD implant include, infection at the surgical site and/or sensitivity to the device material, failure to deliver therapy when it is needed, and receiving extra therapy when it is not needed. Moreover, after receiving an ICD, patient will have limitations with respect to electromagnetic and magnetic radiation, and gas or electric-powered appliances.

Cardiac Rhythm Management Devices Market - Regional Insights

On the basis of region, the global cardiac rhythm management devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in global cardiac rhythm management devices market during the forecast period, due to increasing prevalence of cardiovascular diseases in the region. According to the American Heart Association (AHA), 2017, around 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke. AHA report also stated that direct and indirect costs of cardiovascular diseases and stroke are estimated to account for US$ 316 billion, including health expenditures and lost productivity.

Asia Pacific cardiac rhythm management devices market is expected to witness lucrative growth during the forecast years, owing to high demand for technological advanced products for cardiac rhythm management coupled with rising healthcare concern for stroke prevention associated with atrial fibrillation. According to the Japanese Heart Rhythm Society in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of which 2.9 million may suffer from AF-associated strokes.

Global Cardiac Rhythm Management Devices Market Share (%), By Region, 2017

   Cardiac Rhythm Management Devices  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2018)

Cardiac Rhythm Management Devices Market - Competitive Landscape

Key players operating in the global cardiac rhythm management devices market include Medtronic plc. Abbott Laboratories, Abiomed, Boston Scientific Corporation, Biotronik Se Co Kg, Koninklijke Philips N.V., LivaNova Plc, Cardiac Science Corporation, Schiller Ag, and Zoll Medical Corporation.

Cardiac rhythm management (CRM) is the treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmias can cause a range of problems for patients, from palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices such as pacemakers, cardiac resynchronization therapy (CRT) devices and implantable cardiac defibrillators (ICDs) continue to evolve rapidly in reliability and lifespan. Most CRM devices are implanted under the skin, with one to three leads threaded down a vein to connect to the heart.

Market Dynamics

Increasing incidences of heart failure and arrhythmia have fuelled rapid advancements in cardiac rhythm management (CRM) technologies eventually increasing the demand for CRM devices. According to the study published in 2016, by the Journal of the Formosan Medical Association, around 72 million people are estimated to suffer from atrial fibrillation in Asia by 2050, which is expected to be more than double the combined numbers of patients from the U.S. and Europe.

However, factors such as chances of infections associated with installation of pacemakers in cardiac patients can hamper the cardiac rhythm management devices market growth. Pacemaker surgery can also led to various complications such as bleeding, bruising or swelling at the of area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can reduce adoption of cardiac implants in patients.

Key features of the study:

  • This report provides in-depth analysis of the cardiac rhythm management devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global cardiac rhythm management devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Medtronic plc, Abbott Laboratories, Abiomed, Boston Scientific Corporation, Biotronik Se Co Kg, Koninklijke Philips N.V., LivaNova Plc, Cardiac Science Corporation, Schiller Ag, and Zoll Medical Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global cardiac rhythm management devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cardiac rhythm management devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Cardiac Rhythm Management Devices Market, By Product Type:
    • Cardiac Resynchronization Therapy Devices
      • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
      • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
    • Defibrillator
      • Implantable Cardioverter Defibrillators (ICDS)
      • External Defibrillators
    • Pacemakers
      • Single Chamber Pacemakers
      • Dual Chamber Pacemakers
      • Biventricular Pacemakers
  • Global Cardiac Rhythm Management Devices Market, By End User:
    • Hospital
    • Home Care Settings
    • Ambulatory Care Settings
  • Global Cardiac Rhythm Management Devices Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Cardiac Resynchronization Therapy Devices
          • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
          • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
        • Defibrillator
          • Implantable Cardioverter Defibrillators (ICDS)
          • External Defibrillators
        • Pacemakers
          • Single Chamber Pacemakers
          • Dual Chamber Pacemakers
          • Biventricular Pacemakers
      • By End User:
        • Hospital
        • Home Care Settings
        • Ambulatory Care Settings
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Cardiac Resynchronization Therapy Devices
          • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
          • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
        • Defibrillator
          • Implantable Cardioverter Defibrillators (ICDS)
          • External Defibrillators
        • Pacemakers
          • Single Chamber Pacemakers
          • Dual Chamber Pacemakers
          • Biventricular Pacemakers
      • By End User:
        • Hospital
        • Home Care Settings
        • Ambulatory Care Settings
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Cardiac Resynchronization Therapy Devices
          • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
          • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
        • Defibrillator
          • Implantable Cardioverter Defibrillators (ICDS)
          • External Defibrillators
        • Pacemakers
          • Single Chamber Pacemakers
          • Dual Chamber Pacemakers
          • Biventricular Pacemakers
      • By End User:
        • Hospital
        • Home Care Settings
        • Ambulatory Care Settings
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Cardiac Resynchronization Therapy Devices
          • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
          • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
        • Defibrillator
          • Implantable Cardioverter Defibrillators (ICDS)
          • External Defibrillators
        • Pacemakers
          • Single Chamber Pacemakers
          • Dual Chamber Pacemakers
          • Biventricular Pacemakers
      • By End User:
        • Hospital
        • Home Care Settings
        • Ambulatory Care Settings
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Cardiac Resynchronization Therapy Devices
          • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
          • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
        • Defibrillator
          • Implantable Cardioverter Defibrillators (ICDS)
          • External Defibrillators
        • Pacemakers
          • Single Chamber Pacemakers
          • Dual Chamber Pacemakers
          • Biventricular Pacemakers
      • By End User:
        • Hospital
        • Home Care Settings
        • Ambulatory Care Settings
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Cardiac Resynchronization Therapy Devices
          • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
          • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
        • Defibrillator
          • Implantable Cardioverter Defibrillators (ICDS)
          • External Defibrillators
        • Pacemakers
          • Single Chamber Pacemakers
          • Dual Chamber Pacemakers
          • Biventricular Pacemakers
      • By End User:
        • Hospital
        • Home Care Settings
        • Ambulatory Care Settings
  • Company Profiles
    • Medtronic plc*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Abbott Laboratories
    • Abiomed
    • Boston Scientific Corporation
    • Biotronik Se Co Kg
    • Koninklijke Philips N.V.
    • LivaNova Plc
    • Cardiac Science Corporation
    • Schiller Ag
    • Zoll Medical Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • New Product Launches and Approvals
    • Technological Advancements
    • Regulatory Landscape
    • Reimbursement Scenario
      • North America
      • Europe
      • Asia Pacific
    • Epidemiology Analysis
    • PEST Analysis
    • Porter’s Analysis
  4. Global Cardiac Rhythm Management Devices Market, By Product Type, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Cardiac Resynchronization Therapy Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
        • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
    • Defibrillator
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Implantable Cardioverter Defibrillators (ICDS)
        • External Defibrillators
    • Pacemakers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Single Chamber Pacemakers
        • Dual Chamber Pacemakers
        • Biventricular Pacemakers
  5. Global Cardiac Rhythm Management Devices Market, By End User, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Ambulatory Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Cardiac Rhythm Management Devices Market, By Region, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2016 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Medtronic plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abiomed
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Biotronik Se Co Kg
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Koninklijke Philips N.V.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • LivaNova Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Cardiac Science Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Schiller Ag
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Zoll Medical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  8. Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 28 market data tables and 24 figures on "Cardiac Rhythm Management Devices Market” - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.